FILTER
FILTERED INTERVIEW RESULTS
Kate Collier & Lizle Louw
PARTNERS, WEBBER WENTZEL
GBR meets with law firm Webber Wentzel in South Africa to discuss its role in the mining industry.
Laxman Shekhawat
EXECUTIVE DIRECTOR AND BUSINESS HEAD, VEDANTA ZINC INTERNATIONAL
Vedanta Zinc International describes progress at its operations in Southern Africa.
Nick Tatalias
MANAGING DIRECTOR, METC ENGINEERING
METC Engineering is a medium-sized EPCM company that designs and builds metallurgical plants for mines.
Richard Doyle & Peter Drager
MANAGING DIRECTOR SOUTH AFRICA & HEAD OF DEVELOPMENT (HYBRID AND OFFGRID) EMEA, JUWI
juwi is the leading utility-scale solar PV EPC company in South Africa with 400 MW installed capacity and expanding across Africa.
Gert Van Niekerk
CHAIRMAN, SOUTH AFRICAN DIAMOND PRODUCERS ORGANIZATION (SADPO)
SADPO, which represents the smaller side of the diamond-producing industry in South Africa, explains how the government must alter the regulatory framework for the industry to regain its former sparkle.
Eira Thomas
PRESIDENT & CEO, LUCARA DIAMOND
Lucara Diamond explains how it has managed throughout the pandemic.
Albert Du Preez
SVP, HEAD OF TOMRA MINING
TOMRA Sorting Mining explains the benefits of sensor-based sorting for mining operations beyond industrial minerals and diamonds.
Themba Mkhwanazi
CEO, KUMBA IRON ORE
Kumba Iron Ore is the largest iron ore producer in Africa and the fourth largest iron ore producer in the world.
Veston Malango
CEO, CHAMBER OF MINES NAMIBIA
The Chamber of Mines for Namibia provides an update on the issues currently affecting the country’s mining sector.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
